HIV enhances substance P expression in human immune cells

被引:45
作者
Ho, WZ [1 ]
Lai, JP [1 ]
Li, Y [1 ]
Douglas, SD [1 ]
机构
[1] Univ Penn, Childrens Hosp Philadelphia, Sch Med, Dept Pediat,Div Immunol & Infect Dis, Philadelphia, PA 19104 USA
关键词
lymphocytes; gp120; tachykinin; neuroimmunoregulation; monocyte-derived macrophages;
D O I
10.1096/fj.01-0655fje
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Substance P (SP), a potent modulator of neuroimmunoregulation, is expressed in human immune cells. We observed elevated plasma SP levels in HIV-infected men compared with uninfected subjects. In the present study, we investigated the possible cellular source of the increased SP level caused by HIV infection. Using real-time reverse transcriptase-polymerase chain reaction, we demonstrated that monocyte-derived macrophages (MDM) and lymphocytes from both placental cord blood and adult peripheral blood expressed SP mRNA, which was significantly increased by HIV infection. HIV-induced SP expression was positively related to virus replication in the infected MDM. Purified recombinant HIV envelope glycoprotein 120 (gp120) derived from both the macrophage-tropic strain (MN) and the T lymphocyte-tropic strain (IIIB), when added to MDM cultures, enhanced SP mRNA expression. The gp120-induced SP expression was abrogated by pretreating the cells with soluble CD4. Furthermore, the activation of HIV in the latently infected promonocytic cell line (U1) and T-cell line (ACH-2) up-regulated SP mRNA expression. These data support the hypothesis that interaction of HIV and SP may have significant in vivo relevance to the immunopathogenesis of HIV infection and AIDS.
引用
收藏
页码:616 / +
页数:16
相关论文
共 45 条
[1]   SELECTIVE LOCALIZATION OF VASOACTIVE-INTESTINAL-PEPTIDE AND SUBSTANCE-P IN HUMAN EOSINOPHILS [J].
ALIAKBARI, J ;
SREEDHARAN, SP ;
TURCK, CW ;
GOETZL, EJ .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1987, 148 (03) :1440-1445
[2]   HIV-1 gp120 increases the permeability of rat brain endothelium cultures by a mechanism involving substance P [J].
Annunziata, P ;
Cioni, C ;
Toneatto, S ;
Paccagnini, E .
AIDS, 1998, 12 (18) :2377-2385
[3]  
Azzari C, 1992, Pediatr Med Chir, V14, P577
[5]  
BLACK PH, 1994, ANTIMICROB AGENTS CH, V38, P1
[6]  
BOST K L, 1992, Regional Immunology, V4, P105
[7]   TACHYKININ (SUBSTANCE-P) GENE-EXPRESSION IN LEYDIG-CELLS OF THE HUMAN AND MOUSE TESTIS [J].
CHIWAKATA, C ;
BRACKMANN, B ;
HUNT, N ;
DAVIDOFF, M ;
SCHULZE, W ;
IVELL, R .
ENDOCRINOLOGY, 1991, 128 (05) :2441-2448
[8]  
CLOUSE KA, 1989, J IMMUNOL, V142, P431
[9]  
COVAS MJ, 1994, CLIN EXP IMMUNOL, V96, P384, DOI 10.1111/j.1365-2249.1994.tb06039.x
[10]   Elevated substance p levels in HIV-infected men [J].
Douglas, SD ;
Ho, WZ ;
Gettes, DR ;
Cnaan, A ;
Zhao, HQ ;
Leserman, J ;
Petitto, JM ;
Golden, RN ;
Evans, DL .
AIDS, 2001, 15 (15) :2043-2045